Emergence of high-level resistance to gentamicin and streptomycin in Streptococcus agalactiae in Buenos Aires, Argentina;Emergencia de streptococcus agalactiae con resistencia de alto nivel a gentamicina y estreptomicina en Buenos Aires, Argentina

Revista Espanola de Quimioterapia

Volumn 26, Issue 2, 2013, Pages 112-115

  Villar, Hugo Edgardo ^a   Jugo, Mónica Beatriz ^a  

^a Laboratorio Hidalgo   (Argentina)

Author keywords

Gentamicin; Resistance; Streptococcus agalactiae; Streptomycin

Indexed keywords

GENTAMICIN; STREPTOMYCIN;

ANTIBIOTIC RESISTANCE; ARGENTINA; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; MINIMUM INHIBITORY CONCENTRATION; PREVALENCE; STREPTOCOCCUS AGALACTIAE; VAGINA SMEAR;

ADULT; ANTI-BACTERIAL AGENTS; ARGENTINA; DRUG RESISTANCE, BACTERIAL; FEMALE; GENTAMICINS; HUMANS; MICROBIAL SENSITIVITY TESTS; PREGNANCY; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE; STREPTOMYCIN;

EID: 84890366673     PISSN: 02143429     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. McCracken GH Jr. Group B streptococcus: the new challenge in neonatal infections. J Pediatr 1973; 82:703-6.
2. Bizzarro MJ, Raskind C, Baltimore RS, Gallagher PG. Seventy-five years of neonatal sepsis at Yale: 1928-2003. Pediatrics 2005; 116:595-02.
3. Skoff TH, Farley MM, Petit S et al. Increasing burden of invasive group B streptococcal disease in nonpregnant adults, 1990-2007. Clin Infect Dis 2009; 49: 85-92.
4. Edwards MS, Baker CJ. Group B streptococcal infections in elderly adults. Clin Infect Dis 2005; 41: 839-47.
5. Centers for Disease Control and Prevention. Active Bacterial Core surveillance report, Emerging Infections Program Network, group B Streptococcus. 2010. Disponible en: http://www.cdc.gov/abcs/reports-findings/survreports/gbs10.html.
6. Centers for Disease Control and Prevention. Active Bacterial Core surveillance report, Emerging Infections Program Network, group A Streptococcus. 2007. Disponible en: http://www.cdc.gov/abcs/reports-findings/survreports/gas10.html.
7. Buu-Hoï A, Le Bouguenec C, Horaud T. High-level chromosomal gentamicin resistance in Streptococcus agalactiae (group B). Antimicrob Agents Chemother 1990; 34:985-88.
8. Liddy H, Holliman R Group B Streptococcus highly resistant to gentamicin. J Antimicrob Chemother 2002; 50:142-3.
9. Lopardo HA, Vidal P, Jeric P, Centron D, Paganini H, Facklam RR, et al. Six-month multicenter study on invasive infections due to group B streptococci in Argentina. J Clin Microbiol 2003; 41:4688-94.
10. Kaufhold A, Podbielski A, Horaud T, Ferrieri P. Identical genes confer high-level resistance to gentamicin upon Enterococcus faecalis, Enterococcus faecium, and Streptococcus agalactiae. Antimicrob Agents Chemother 1992; 36:1215-8.
11. Villar HE, Jugo MB, Estevez R, Baserni MN. Elevada prevalencia de Streptococcus agalactiae resistente a eritromicina, clindamicina y fluoroquinolonas en Buenos Aires, Argentina. Rev Panam Infectol. En prensa
12. Clinical and Laboratory Standards Institute. 2011. Performance standards for antimicrobial susceptibility testing. Twenty-first informational supplement, M100-S21. Clinical and Laboratory Standards Institute, Wayne, PA
13. Lambertsen L, Ekelund K, Skovsted IC, Liboriussen A, Slotved HC. Characterization of invasive group B streptococci from adults in Denmark 1999 to 2004. Eur J Clin Microbiol Infect Dis 2010; 29: 1071-77.
14. Phares CR, Lynfield R, Farley MM e Mohle-Boetani J, Harrison LH, Petit S et al. Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005. JAMA 2008; 299: 2056-65.
15. Poyart C, Jardy L, Quesne G, Berche P, Trieu-Cuot P. Genetic Basis of Antibiotic Resistance in Streptococcus agalactiae strains isolated in a French Hospital. Antimicrob Agents Chemother 2003; 47: 794-7.
16. Granlund M, Axemo P, Bremme K, Bryngelsson AL, Carlsson Wallin M, Ekström CM et al. Antimicrobial resistance in colonizing Group B Streptococci before implementation of a Swedish intrapartum antibiotic prophylaxis program. Eur J Clin Microbiol Infect Dis 2010 29:1195-201.
17. Bonafede ME, Carias LL, Rice LB. Enterococcal transposon Tn5384: evolution of a composite transposon through cointegration of enterococcal and staphylococcal plasmids. Antimicrob Agents Chemother1997; 41:1854-8.
18. Rice LB, Carias LL., Marshall SH. Tn5384, a composite enterococcal mobile element conferring resistance to erythromycin and gentamicin whose ends are directly repeated copies of IS256. Antimicrob Agents Chemother1995; 39:1147-53.